Ana Ruiz-Garcia, Pharm.D, PhD

Executive Director, Head of Pharmacometrics
Gilead Sciences, Inc.

Poster(s):

• (T1430-05-27) Physiologically Based Pharmacokinetic Modeling to Inform Lenacapavir Dose Regimen when Co-Administered with Rifamycins in Participants with Tuberculosis
  Tuesday, November 11, 2025

  2:30 PM - 3:30 PM CT